Showing results (141-150 of 180) with videos related to
Sort By:
Pageof 18
International Journal of Molecular Sciences|August 6, 2020
Expression of Nectin-4 and PD-L1 in Upper Tract Urothelial CarcinomaEisuke Tomiyama, Kazutoshi Fujita, Maria Del Carmen Rodriguez Pena, et al.British Journal of Cancer|May 5, 2025
Prognostic significance of circulating tumor DNA alterations in advanced renal cell carcinoma from SCRUM-Japan MONSTAR-SCREEN: a nationwide genomic profiling projectTaigo Kato, Masaki Shiota, Koshiro Nishimoto, et al.BMC Urology|July 9, 2025
Preoperative CRP is a predictive factor for prolonged hospital stay after radical cystectomy for bladder cancerTakuji Hayashi, Atsunari Kawashima, Takeshi Ujike, et al.Anticancer Research|September 4, 2020
A Potential Mechanism of Anticancer Immune Response Coincident With Immune-related Adverse Events in Patients With Renal Cell CarcinomaTaigo Kato, Eisuke Tomiyama, Yoko Koh, et al.International Journal of Clinical Oncology|February 11, 2025
Real-world outcomes with avelumab + axitinib in patients with advanced renal cell carcinoma in Japan: subgroup analyses from the J-DART2 study by International Metastatic Renal Cell Carcinoma Database Consortium risk classificationJunya Furukawa, Taigo Kato, Toshinari Yamasaki, et al.Journal for Immunotherapy of Cancer|May 2, 2025
Selection of therapeutically effective T-cell receptors from the diverse tumor-bearing repertoireLeonie Rosenberger, Leo Hansmann, Vasiliki Anastasopoulou, et al.Oncoimmunology|May 10, 2019
TCR sequencing analysis of cancer tissues and tumor draining lymph nodes in colorectal cancer patientsTatsuo Matsuda, Eisaku Miyauchi, Yu-Wen Hsu, et al.Biomarker Research|November 26, 2024
GDF15 propeptide promotes bone metastasis of castration-resistant prostate cancer by augmenting the bone microenvironmentGaku Yamamichi, Taigo Kato, Noriaki Arakawa, et al.International Journal of Urology : Official Journal of the Japanese Urological Association|December 19, 2023
Real-world outcomes of avelumab plus axitinib as first-line therapy in patients with advanced renal cell carcinoma in Japan: A multicenter, retrospective, observational study (J-DART)Taigo Kato, Yuzo Nakano, Fumiya Hongo, et al.Oncotarget|May 4, 2018
A pilot study of durvalumab and tremelimumab and immunogenomic dynamics in metastatic breast cancerCesar August Santa-Maria, Taigo Kato, Jae-Hyun Park, et al.Pageof 18